ICD-10-CM Billable Code

F15.14

Other stimulant abuse with stimulant-induced mood disorder

Clinical Classification Guidelines

Inclusion Terms

  • Amphetamine or other stimulant use disorder, mild, with amphetamine or other stimulant induced bipolar or related disorder
  • Amphetamine or other stimulant use disorder, mild, with amphetamine or other stimulant induced depressive disorder

Medical Intelligence & Overview

ICD-10 code F15.14 describes a condition where an individual abuses stimulants such as amphetamines and experiences mood disturbances induced by their use. This includes mild cases where stimulant use triggers bipolar-like episodes or depressive states. Recognizing this diagnosis helps healthcare providers address both substance use and mental health symptoms simultaneously, aiming for comprehensive treatment and recovery.

Causes & Symptoms

Clinical Causes: Recreational use or misuse of stimulants like amphetamines, methylphenidate, or other substances classified as stimulants. Self-medication for perceived energy or mood enhancement, which can lead to dependence. Psychosocial factors such as stress, peer influence, or mental health conditions that increase likelihood of stimulant misuse. Underlying mental health issues, including depression or bipolar disorder, which may predispose individuals to stimulants abuse. Environmental or socioeconomic factors that contribute to substance use behaviors.

Key Symptoms: Elevated energy levels and increased activity Euphoria or heightened mood episodes Irritability or agitation Decreased need for sleep Rapid speech or racing thoughts Difficulty concentrating or impulsivity Depressive mood episodes following stimulant effects Mood swings associated with stimulant use Potential psychotic symptoms such as paranoia or hallucinations during high doses

Diagnostic & Treatment

Diagnosis Path: Diagnosis involves a thorough clinical assessment including a detailed substance use history and evaluation of mood symptoms. Healthcare providers may use screening tools and diagnostic interviews aligned with ICD-10 criteria. Laboratory tests can support the assessment by detecting recent stimulant use. Differential diagnosis is crucial to distinguish between primary mood disorders and stimulant-induced mood disturbances, especially considering the timing and context of symptoms.

Treatment Protocols: Behavioral therapies, such as cognitive-behavioral therapy (CBT), to address substance use behaviors and underlying mental health issues Motivational interviewing to enhance readiness for change Medication-assisted treatment may be considered for co-occurring mental health conditions, though no specific medications are approved solely for stimulant dependence Monitoring and managing mood symptoms to prevent relapse and stabilize emotional states Support groups and community resources to sustain recovery Long-term follow-up to prevent relapse and manage ongoing mental health challenges

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is F15.14 a billable ICD-10 code?
Yes, F15.14 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report F15.14?
Clinical documentation must specify the nature of Other stimulant abuse with stimulant-induced mood disorder and any associated comorbidities for accurate reporting.

Cite this Clinical Reference